News

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
Former Surgeon General Jerome Adams, who served under Trump’s first administration, criticized Kennedy’s move to cancel $500 million for mRNA projects. Adams said in a post on social media platform X ...
The Phase 1 trial will involve 56 healthy, HIV-negative adult participants. The company will give 48 of those individuals the mRNA vaccine. Thirty-two of that group will also receive the booster ...
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...